Medical and pharmaceutical preparations for the treatment of myelofibrosis and muscular dystrophy, both prescription and over-the-counter, for use in connection with humans

[ Testing, analysis, and evaluation of pharmaceutical products; development and evaluation of pharmaceutical test methods; consulting services in the field of testing, analysis and research of pharmaceutical products ]

[ Consulting services relating to regulatory compliance in the pharmaceutical industry; consulting services in the field of pharmaceutical licensing; consulting services in the field of licensing of proprietary technologies in the pharmaceutical industry ]